Sucampo Pharmaceuticals Inc (SCMP) - Financial and Strategic SWOT Analysis Review

June 2017 | 53 pages | ID: SA0DCC33CA0EN
GlobalData

Abstracts

Sucampo Pharmaceuticals Inc (SCMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sucampo Pharmaceuticals Inc (Sucampo) is a biopharmaceutical company which conducts research, discovers, develops and commercializes proprietary drugs to address unmet medical needs. Its drugs are indicated for the treatment of gastrointestinal, ophthalmic, and cancer-based inflammatory disorders. Sucampo’s marketed products include Amitiza (lubiprostone), which is indicated for the treatment of chronic idiopathic constipation in adults, irritable bowel syndrome with constipation in adult women, opioid-induced constipation (OIC) in patients with chronic non-cancer pain; Rescula (unoprostone isopropyl), used to lower intraocular pressure. Other prostone-based product candidates under development include lubiprostone and CPP

1X/Sulindac combination product. The company, through its subsidiaries, operates in the UK, the US, Japan, and Switzerland. Sucampo is headquartered in Rockville, Maryland, the US.

Sucampo Pharmaceuticals Inc Key Recent Developments

May 03,2017: Sucampo Reports First Quarter 2017 Financial Results
Mar 08,2017: Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results
Nov 09,2016: Sucampo Reports Third Quarter 2016 Financial Results
Aug 03,2016: Sucampo Reports Second Quarter 2016 Financial Results
Jul 29,2016: Paul Edick Joins Sucampo’s Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Sucampo Pharmaceuticals Inc - Key Facts
Sucampo Pharmaceuticals Inc - Key Employees
Sucampo Pharmaceuticals Inc - Key Employee Biographies
Sucampo Pharmaceuticals Inc - Major Products and Services
Sucampo Pharmaceuticals Inc - History
Sucampo Pharmaceuticals Inc - Company Statement
Sucampo Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Sucampo Pharmaceuticals Inc - Business Description
Sucampo Pharmaceuticals Inc - Corporate Strategy
Sucampo Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Sucampo Pharmaceuticals Inc - Strengths
Sucampo Pharmaceuticals Inc - Weaknesses
Sucampo Pharmaceuticals Inc - Opportunities
Sucampo Pharmaceuticals Inc - Threats
Sucampo Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Sucampo Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 03, 2017: Sucampo Reports First Quarter 2017 Financial Results
Mar 08, 2017: Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results
Nov 09, 2016: Sucampo Reports Third Quarter 2016 Financial Results
Aug 03, 2016: Sucampo Reports Second Quarter 2016 Financial Results
Jul 29, 2016: Paul Edick Joins Sucampo’s Board of Directors
May 04, 2016: Sucampo Reports Strong Results for First Quarter of 2016
Mar 08, 2016: Sucampo Reports Continued Strong Performance for Fourth Quarter and Full Year 2015
Jan 07, 2016: Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Sucampo Pharmaceuticals Inc, Key Facts
Sucampo Pharmaceuticals Inc, Key Employees
Sucampo Pharmaceuticals Inc, Key Employee Biographies
Sucampo Pharmaceuticals Inc, Major Products and Services
Sucampo Pharmaceuticals Inc, History
Sucampo Pharmaceuticals Inc, Other Locations
Sucampo Pharmaceuticals Inc, Subsidiaries
Sucampo Pharmaceuticals Inc, Key Competitors
Sucampo Pharmaceuticals Inc, Ratios based on current share price
Sucampo Pharmaceuticals Inc, Annual Ratios
Sucampo Pharmaceuticals Inc, Annual Ratios (Cont.1)
Sucampo Pharmaceuticals Inc, Annual Ratios (Cont.2)
Sucampo Pharmaceuticals Inc, Interim Ratios
Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Sucampo Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Sucampo Pharmaceuticals Inc, Performance Chart (2012 - 2016)
Sucampo Pharmaceuticals Inc, Ratio Charts
Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Sucampo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Valeant Pharmaceuticals International Inc
Synergy Pharmaceuticals Inc
Shionogi Inc
Progenics Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc
AstraZeneca Plc